Home  >  Speakers  >  Nigel Horscroft
Nigel Horscroft

Nigel Horscroft DPhil

Area Head | Tubingen, Baden-Wurttemberg    Germany
Biochemistry And Molecular Genetics, Immunology And Microbiology
Neurodevelopmental Disorders, Borna Disease Virus,...More
Spoken at 4 events

Biography :

Dr Nigel Horscroft is Area Head for Molecular Therapy at CureVac AG. Dr Horscroft has a BSc in Applied and Industrial Biology from London South Bank University and received his DPhil in Biochemistry from Oxford University where he studied Bluetongue Virus (BTV) replication at the NERC Institute of Virology and Environmental Microbiology. He then joined the Department of Neurology at the University of California – Irvine for post-doctoral studies on Borna Disease Virus (BDV) and infectious models of neurodevelopmental disorders.

Following his post-doctoral studies, Dr Horscroft remained in California and transitioned to the industry when he joined ICN Pharmaceuticals, which later became Valeant Pharmaceuticals. He returned to the UK to join Pfizer Global Research and Development in Sandwich and headed a variety of discovery projects. He then took on the role of Head of Research at Pike Pharma in Zurich, Switzerland. In 2012 Dr Horscroft joined CureVac in Tubingen, Germany.

*** **** *****
For speaker's contact information - Contact us


Biochemistry and Molecular Genetics, Immunology and Microbiology

Interested Topics

Neurodevelopmental Disorders, Borna Disease Virus, Molecular Biology, Cellular Biology, Pharmacology, Virology, Biochemistry, Immunology

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.


English, German

Conference Session Materials

The conference session material has yet to be added by the speaker.

Onsite to Virtual Conference

Market your online event to Million plus Healthcare professionals.